JP2007501800A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007501800A5 JP2007501800A5 JP2006522776A JP2006522776A JP2007501800A5 JP 2007501800 A5 JP2007501800 A5 JP 2007501800A5 JP 2006522776 A JP2006522776 A JP 2006522776A JP 2006522776 A JP2006522776 A JP 2006522776A JP 2007501800 A5 JP2007501800 A5 JP 2007501800A5
- Authority
- JP
- Japan
- Prior art keywords
- carbon atoms
- alkyl
- group
- lower alkyl
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49313803P | 2003-08-07 | 2003-08-07 | |
| US53373403P | 2003-12-31 | 2003-12-31 | |
| PCT/US2004/025564 WO2005013949A2 (en) | 2003-08-07 | 2004-08-06 | Method for treating cachexia with retinoid ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007501800A JP2007501800A (ja) | 2007-02-01 |
| JP2007501800A5 true JP2007501800A5 (enExample) | 2007-09-20 |
Family
ID=34138739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006522776A Pending JP2007501800A (ja) | 2003-08-07 | 2004-08-06 | レチノイドリガンドを用いて悪液質を処置するための方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1653939A2 (enExample) |
| JP (1) | JP2007501800A (enExample) |
| AU (1) | AU2004263156B2 (enExample) |
| CA (1) | CA2535260A1 (enExample) |
| WO (1) | WO2005013949A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT1937244T (lt) | 2005-09-30 | 2018-11-12 | Io Therapeutics, Llc | Vėžio gydymas specifiniais rxr agonistais |
| EP2056805B1 (en) * | 2006-08-16 | 2011-05-25 | Action Medicines, S.L. | Use of 2, 5-dihydroxybenzene derivatives for the treatment of tissue reactive diseases |
| WO2011006157A2 (en) * | 2009-07-10 | 2011-01-13 | Case Western Reserve University | Rxr agonist compounds and methods |
| EP2556827A1 (en) * | 2011-08-11 | 2013-02-13 | Acadia Pharmaceuticals Inc. | Treatment of neurodegenerative diseases |
| JP2014527083A (ja) * | 2011-09-15 | 2014-10-09 | アリゾナ ボード オブ リージェンツ， ア ボディー コーポレイト オブ ザ ステート オブ アリゾナ， アクティング フォー アンド オン ビハーフ オブ アリゾナ ステート ユニバーシティー | 治療用化合物 |
| CN110151745A (zh) | 2011-12-13 | 2019-08-23 | Io治疗公司 | 使用rxr激动剂的自身免疫紊乱的治疗 |
| US10653650B2 (en) | 2011-12-13 | 2020-05-19 | Io Therapeutics, Inc. | Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists |
| RU2720237C2 (ru) | 2013-11-18 | 2020-04-28 | Форма Терапеутикс, Инк. | Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет |
| BR122019007990B1 (pt) | 2013-11-18 | 2021-05-04 | Forma Therapeutics, Inc | Composto, e, composição farmacêutica |
| KR102549273B1 (ko) | 2016-03-10 | 2023-06-28 | 아이오 테라퓨틱스, 인크. | Rxr 작용제 및 갑상선 호르몬의 조합을 사용한 자가면역 질환의 치료 |
| NZ745704A (en) * | 2016-03-10 | 2019-04-26 | Io Therapeutics Inc | Treatment of muscular disorders with combinations of rxr agonists and thyroid hormones |
| US10231947B2 (en) | 2017-01-23 | 2019-03-19 | Arizona Board Of Regents On Behalf Of Arizona State University | Isochroman compounds and methods of use thereof |
| US10238655B2 (en) | 2017-01-23 | 2019-03-26 | Arizona Board Of Regents On Behalf Of Arizona State University | Dihydroindene and tetrahydronaphthalene compounds |
| US10238626B2 (en) | 2017-01-23 | 2019-03-26 | Arizona Board Of Regents On Behalf Of Arizona State University | Therapeutic compounds |
| EP3684348A4 (en) | 2017-09-20 | 2021-08-18 | IO Therapeutics, Inc. | TREATMENT OF DISEASES WITH ETERS FROM SELECTIVE RXR AGONISTS |
| US10966950B2 (en) | 2019-06-11 | 2021-04-06 | Io Therapeutics, Inc. | Use of an RXR agonist in treating HER2+ cancers |
| EP4444287A4 (en) | 2021-12-07 | 2025-05-28 | Io Therapeutics, Inc. | USE OF AN RXR AGONIST AND TAXANES FOR THE TREATMENT OF HER2+ CANCER |
| KR20240115316A (ko) | 2021-12-07 | 2024-07-25 | 아이오 테라퓨틱스, 인크. | 약물 내성 her2+ 암 치료에서의 rxr 작용제의 용도 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6320074B1 (en) * | 1992-04-22 | 2001-11-20 | Ligand Pharmaceuticals Incorporated | Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors |
| KR100363545B1 (ko) * | 1994-08-10 | 2003-02-19 | 에프. 호프만-라 로슈 아게 | 레틴산x-수용체리간드 |
| IL116259A (en) * | 1994-12-19 | 2000-07-16 | American Cyanamid Co | Analogs of 9-cis retinoic acid and their use |
| US5917082A (en) * | 1995-06-06 | 1999-06-29 | Allergan Sales, Inc. | 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| US5675033A (en) * | 1995-06-06 | 1997-10-07 | Allergan | 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
-
2004
- 2004-08-06 AU AU2004263156A patent/AU2004263156B2/en not_active Ceased
- 2004-08-06 JP JP2006522776A patent/JP2007501800A/ja active Pending
- 2004-08-06 WO PCT/US2004/025564 patent/WO2005013949A2/en not_active Ceased
- 2004-08-06 EP EP04780406A patent/EP1653939A2/en not_active Withdrawn
- 2004-08-06 CA CA002535260A patent/CA2535260A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113365998A (zh) | 用于parp抑制剂的吲哚并七元酰肟类似物 | |
| US9511060B2 (en) | Non-flushing niacin analogues, and methods of use thereof | |
| JP2009530398A5 (enExample) | ||
| JP2009539828A5 (enExample) | ||
| JP2013544887A5 (enExample) | ||
| JP2004526745A5 (enExample) | ||
| JP2004524312A5 (enExample) | ||
| JP2009114217A5 (enExample) | ||
| JP2010513224A5 (enExample) | ||
| JP2018135343A5 (enExample) | ||
| JP2012521429A5 (enExample) | ||
| JP2012505836A5 (enExample) | ||
| JP2004517099A5 (enExample) | ||
| JP2007509055A5 (enExample) | ||
| JP2009507896A5 (enExample) | ||
| JP2009504748A5 (enExample) | ||
| JP2010265315A (ja) | 癒着の予防及び／又は治療のための医薬 | |
| JP2002521334A5 (enExample) | ||
| JP2006524252A5 (enExample) | ||
| JP2021525787A5 (enExample) | ||
| JP2007517037A5 (enExample) | ||
| WO2005013949A2 (en) | Method for treating cachexia with retinoid ligands | |
| CN1159305C (zh) | 新的2-(n-氰基亚氨基)噻唑烷-4-酮衍生物 | |
| JP2007515467A5 (enExample) | ||
| RU2004117595A (ru) | Производные пиридина в качестве лигандов рецептора nmda |